Transactions
22
Insider / Medpace Holdings, Inc.
BURWIG SUSAN E
Exec. VP, Operations at Medpace Holdings, Inc.
- Company
- Medpace Holdings, Inc.
- Ticker
- MEDP
- First filing on record
- October 29, 2025
- Latest trade on record
- October 21, 2026
- SEC filings
- EDGAR ↗
BURWIG SUSAN E, Exec. VP, Operations at Medpace Holdings, Inc., has disclosed 22 transactions in MEDP since October 29, 2025: 0 purchases (0 open-market buys) and 4 sales, worth about $35.9M at the reported prices. The latest was filed October 23, 2026, 2 days after the trade.
Open-market buys
0
Sales
4
Avg. disclosure lag
2.4d
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
Bought (above the line)Sold (below the line)Other transaction
In the last 12 months BURWIG SUSAN E made no purchases and 4 sales worth $29M, plus 18 other transactions. Dot size is the dollar amount.
Portfolio mix
Which stocks does this person trade most? Tile size is dollars traded, all time on record.
BURWIG SUSAN E has traded 1 stock on record; the largest by dollars is MEDP.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
On timeLate
0 of 13 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| M | Option exercise or conversion | 16 | 107,368 | $7.1M |
| S | Open-market sale | 4 | 47,500 | $28.8M |
| A | Grant or award | 2 | 15,000 | — |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 15 | 0 | 1 · $4.5M |
| 2025 | 7 | 0 | 3 · $24.3M |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| MEDP | Option / conversion M | October 21, 2026 | October 23, 2026 | 2d | 2,700 | — | — | derivative | Form 4 ↗ | |
| MEDP | Option / conversion M | October 21, 2026 | October 23, 2026 | 2d | 2,700 | $167 | $450K | Form 4 ↗ | ||
| MEDP | Option / conversion M | October 12, 2026 | October 14, 2026 | 2d | 3,000 | — | — | derivative | Form 4 ↗ | |
| MEDP | Option / conversion M | October 12, 2026 | October 14, 2026 | 2d | 3,000 | $167 | $500K | Form 4 ↗ | ||
| MEDP | Option / conversion M | October 7, 2026 | October 9, 2026 | 2d | 2,000 | — | — | derivative | Form 4 ↗ | |
| MEDP | Option / conversion M | October 7, 2026 | October 9, 2026 | 2d | 2,000 | $167 | $333K | Form 4 ↗ | ||
| MEDP | Option / conversion M | September 15, 2026 | September 17, 2026 | 2d | 3,000 | — | — | derivative | Form 4 ↗ | |
| MEDP | Option / conversion M | September 15, 2026 | September 17, 2026 | 2d | 3,000 | $167 | $500K | Form 4 ↗ | ||
| MEDP | Sell S | July 28, 2026 | July 29, 2026 | 1d | 7,500 | $600 | $4.5M | Form 4 ↗ | ||
| MEDP | Other A | April 24, 2026 | April 28, 2026 | 4d | 5,000 | — | — | derivative | Form 4 ↗ | |
| MEDP | Other A | April 24, 2026 | April 28, 2026 | 4d | 10,000 | — | — | derivative | Form 4 ↗ | |
| MEDP | Option / conversion M | March 18, 2026 | March 19, 2026 | 1d | 12,000 | — | — | derivative | Form 4 ↗ | |
| MEDP | Option / conversion M | March 18, 2026 | March 19, 2026 | 1d | 12,000 | $167 | $2.0M | Form 4 ↗ | ||
| MEDP | Option / conversion M | February 13, 2026 | February 17, 2026 | 4d | 10,984 | — | — | derivative | Form 4 ↗ | |
| MEDP | Option / conversion M | February 13, 2026 | February 17, 2026 | 4d | 10,984 | $108 | $1.2M | Form 4 ↗ | ||
| MEDP | Option / conversion M | December 5, 2025 | December 9, 2025 | 4d | 10,000 | — | — | derivative | Form 4 ↗ | |
| MEDP | Option / conversion M | December 5, 2025 | December 9, 2025 | 4d | 10,000 | $108 | $1.1M | Form 4 ↗ | ||
| MEDP | Option / conversion M | December 2, 2025 | December 4, 2025 | 2d | 10,000 | — | — | derivative | Form 4 ↗ | |
| MEDP | Option / conversion M | December 2, 2025 | December 4, 2025 | 2d | 10,000 | $108 | $1.1M | Form 4 ↗ | ||
| MEDP | Sell S | November 24, 2025 | November 26, 2025 | 2d | 20,000 | $609 | $12.2M | Form 4 ↗ | ||
| MEDP | Sell S | November 11, 2025 | November 12, 2025 | 1d | 18,000 | $605 | $10.9M | Form 4 ↗ | ||
| MEDP | Sell S | October 27, 2025 | October 29, 2025 | 2d | 2,000 | $605 | $1.2M | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| October 23, 2026 | Form 4 | 0001677418-26-000016 | 2 | published | EDGAR ↗ |
| October 14, 2026 | Form 4 | 0001677418-26-000014 | 2 | published | EDGAR ↗ |
| October 9, 2026 | Form 4 | 0001677418-26-000012 | 2 | published | EDGAR ↗ |
| September 17, 2026 | Form 4 | 0001677418-26-000010 | 2 | published | EDGAR ↗ |
| July 29, 2026 | Form 4 | 0001677418-26-000008 | 1 | published | EDGAR ↗ |
| April 28, 2026 | Form 4 | 0001677418-26-000006 | 2 | published | EDGAR ↗ |
| March 19, 2026 | Form 4 | 0001677418-26-000004 | 2 | published | EDGAR ↗ |
| February 17, 2026 | Form 4 | 0001677418-26-000002 | 2 | published | EDGAR ↗ |
| December 9, 2025 | Form 4 | 0001677418-25-000018 | 2 | published | EDGAR ↗ |
| December 4, 2025 | Form 4 | 0001677418-25-000016 | 2 | published | EDGAR ↗ |
| November 26, 2025 | Form 4 | 0001677418-25-000014 | 1 | published | EDGAR ↗ |
| November 12, 2025 | Form 4 | 0001677418-25-000012 | 1 | published | EDGAR ↗ |
| October 29, 2025 | Form 4 | 0001677418-25-000010 | 1 | published | EDGAR ↗ |
Other insiders at Medpace Holdings, Inc.
- Troendle August J. CEO 41 rows
- Kraft Robert O. Director 18 rows
- McCarthy Cornelius P. III Director 16 rows
- Carley Brian T Director 15 rows
- EWALD STEPHEN P General Counsel & Corp. Secy. 12 rows
- Brady Kevin M. CFO & Treasurer 11 rows
- DAVENPORT FRED B JR Director 11 rows
- GEIGER JESSE J President 10 rows
- Gwadry-Sridhar Femida H. Director 1 row
- Zander Dani S. Director 1 row
Everyone on file, with contracts and lobbying under the company's name: Medpace Holdings, Inc..
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Options and derivatives on Form 4 Table I = shares. Table II = options and other derivatives.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 13 | 22 | October 29, 2025 | October 23, 2026 | Form 4 list on EDGAR |
Site built October 27, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.